MRONJ risk of adjuvant bisphosphonates in early stage breast cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Dentistry
Link
http://www.nature.com/articles/sj.bdj.2017.1039.pdf
Reference28 articles.
1. Ruggiero S L, Dodson T B, Fantasia J et al. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw-2014 update. J Oral Maxillofac Surg 2014; 72: 1938–1956.
2. Patel V, Kelleher M, Sproat C, Kwok J, and McGurk M . New cancer therapies and jaw necrosis. Br Dent J 2015; 219: 203–207.
3. Rosen L S, Gordon D, Tchekmedyian S et al. Zoledronic Acid Versus Placebo in the Treatment of Skeletal Metastases in Patients With Lung Cancer and Other Solid Tumours: A Phase III, Double-Blind, Randomized Trial – The Zoledronic Acid Lung Cancer and Other Solid Tumours Study Group. J Clin Oncol 2003; 21: 150–157.
4. Berenson J R, Lichtenstein A, Porter L et al. Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group. J Clin Oncol 1998; 16: 593–602.
5. Coleman R E . Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity. Clinical Cancer Research 2006; 12: 6243s–6249s.
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Oral surgery: what challenges and opportunities are there on the horizon?;Dental Update;2023-05-02
2. Osteonecrosis of the jaw in primary dental care: Recognition and referral;Primary Dental Journal;2022-09
3. The presenting dental status of solid tumours with bone metastases requiring bone-targeting agents - part 4: miscellaneous cancers;British Dental Journal;2022-02-25
4. The presenting dental status of solid tumours with bone metastases requiring bone-targeting agents - part 2: breast cancer;British Dental Journal;2022-01-28
5. The presenting dental status of solid tumours with bone metastases requiring bone-targeting agents - part 1: an overview;British Dental Journal;2022-01-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3